The proto-oncogene c-myc in hematopoietic development and leukemogenesis
- 13 May 2002
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 21 (21) , 3414-3421
- https://doi.org/10.1038/sj.onc.1205400
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 87 references indexed in Scilit:
- Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiationOncogene, 2002
- MM-1, a c-Myc-binding Protein, Is a Candidate for a Tumor Suppressor in Leukemia/Lymphoma and Tongue CancerJournal of Biological Chemistry, 2001
- Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during LymphomagenesisMolecular and Cellular Biology, 2001
- Activation of Protein Kinase C Induces Nuclear Translocation of RFX1 and Down-regulates c-myc via an Intron 1 X Box in Undifferentiated Leukemia HL-60 CellsPublished by Elsevier ,2000
- The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death programOncogene, 2000
- Expression of BCR – ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferationOncogene, 1999
- Myc—Max—Mad: a transcription factor network controlling cell cycle progression, differentiation and deathCurrent Opinion in Genetics & Development, 1994
- Control of Granulocytes and Macrophages: Molecular, Cellular, and Clinical AspectsScience, 1991
- The Molecular Control of Blood Cell DevelopmentScience, 1987
- Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphomaNature, 1983